This document is an excerpt from the EUR-Lex website
Document 62017TB0157
Case T-157/17: Order of the General Court of 22 January 2018 — Cristalfarma v EUIPO – Novartis (ILLUMINA) (EU trade mark — Opposition proceedings — Application for EU word mark ILLUMINA — Revocation of the contested decision — Action rendered devoid of purpose — No need to adjudicate)
Case T-157/17: Order of the General Court of 22 January 2018 — Cristalfarma v EUIPO – Novartis (ILLUMINA) (EU trade mark — Opposition proceedings — Application for EU word mark ILLUMINA — Revocation of the contested decision — Action rendered devoid of purpose — No need to adjudicate)
Case T-157/17: Order of the General Court of 22 January 2018 — Cristalfarma v EUIPO – Novartis (ILLUMINA) (EU trade mark — Opposition proceedings — Application for EU word mark ILLUMINA — Revocation of the contested decision — Action rendered devoid of purpose — No need to adjudicate)
OJ C 94, 12.3.2018, p. 26–27
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
- Date of document:
- 22/01/2018
- Date lodged:
- 10/03/2017
- Author:
- General Court
- Form:
- Judicial information
- Authentic language:
- English
- Type of procedure:
- Action for annulment
- Link
- Select all documents mentioning this document
- Case affecting:
-
- Related EU case-law document 62017TO0157
- Link
- EUROVOC descriptor:
|
12.3.2018 |
EN |
Official Journal of the European Union |
C 94/26 |
Order of the General Court of 22 January 2018 — Cristalfarma v EUIPO – Novartis (ILLUMINA)
(Case T-157/17) (1)
((EU trade mark - Opposition proceedings - Application for EU word mark ILLUMINA - Revocation of the contested decision - Action rendered devoid of purpose - No need to adjudicate))
(2018/C 094/35)
Language of the case: English
Parties
Applicant: Cristalfarma Srl (Milan, Italy) (represented by: R. Almaraz Palmero, lawyer)
Defendant: European Union Intellectual Property Office (represented by: M. King and D. Gája, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO intervening before the General Court: Novartis AG (Basle, Switzerland)
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 11 January 2017 (Case R 1187/2016-4), relating to opposition proceedings between Novartis and Cristalfarma.
Operative part of the order
|
1. |
The request made by Cristalfarma Srl for a stay of the proceedings is rejected; |
|
2. |
There is no longer any need to adjudicate on the action; |
|
3. |
The European Union Intellectual Property Office (EUIPO) shall bear its own costs and pay those incurred by Cristalfarma; |
|
4. |
Novartis AG shall bear its own costs. |
